Chautauqua Capital Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
$3.58M Buy
29,926
+13,302
+80% +$1.54M 1.13% 14
2015
Q3
$1.8M Sell
16,624
-38,568
-70% -$4.79M 0.59% 22
2015
Q2
$6.39M Buy
55,192
+685
+1% +$78.3K 1.55% 19
2015
Q1
$6.28M Sell
54,507
-29,632
-35% -$3.54M 1.6% 18
2014
Q4
$9.41M Buy
84,139
+2,348
+3% +$248K 2.84% 11
2014
Q3
$7.75M Buy
81,791
+69,745
+579% +$6.29M 2.53% 10
2014
Q2
$1.03M Buy
+12,046
New +$916K 0.36% 24

Other funds holding CELG

Chautauqua Capital Management's CELG Position: Q4 2015 in Review

Chautauqua Capital Management increased its Celgene Corp (CELG) stake by 80% in Q4 2015, buying an estimated $1.54M and bringing the position to 29,926 shares worth $3.58M. The position accounts for 1.13% of the portfolio, ranked #14.

Chautauqua Capital Management first reported a position in CELG in Q2 2014 and has held it in 7 quarters since. The position peaked at $9.41M in Q4 2014. 1,246 funds tracked by Wall St. Rank hold CELG as of Q4 2015.

  • Chautauqua Capital Management held 29,926 shares of Celgene Corp worth $3.58M as of Q4 2015.
  • Chautauqua Capital Management bought 13,302 Celgene Corp shares in Q4 2015, an estimated $1.54M.
  • Celgene Corp made up 1.13% of Chautauqua Capital Management's portfolio in Q4 2015, its #14 holding.
  • Chautauqua Capital Management first reported a position in Celgene Corp in Q2 2014 and has held it in 7 quarters since.
  • Chautauqua Capital Management's Celgene Corp position peaked at $9.41M in Q4 2014.
  • 1,246 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2015.

Based on Chautauqua Capital Management's 13F filing for Q4 2015, filed 22 Jan 2016.